Evidence map›Paper›PMID 21521526›Full record

ArticleBreast cancer research : BCR2011

Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

Max Yan, Nicholas Jene, David Byrne, Ewan K A Millar, Sandra A O'Toole, Catriona M McNeil, Gaynor J Bates, Adrian L Harris, Alison H Banham, Robert L Sutherland and 1 more

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 7 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 7 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Regulatory T cells in cancer and inflammation.Signal transduction and targeted therapy · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Tumor hypoxia shapes natural killer cell anticancer activities.Journal of molecular medicine (Berlin, Germany) · 2025
    Review
  17. Article
  18. Article
  19. Review
  20. Understanding the role of TNFR2 signaling in the tumor microenvironment of breast cancer.Journal of experimental & clinical cancer research : CR · 2024
    Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Max YanDepartment of Pathology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Melbourne, VIC 3002, Australia. max.yan@sesiahs.health.nsw.gov.au
Nicholas Jene
David Byrne
Ewan K A Millar
Sandra A O'Toole
Catriona M McNeil
Gaynor J Bates
Adrian L Harris
Alison H Banham
Robert L Sutherland
Stephen B Fox
Peter MacCallum Cancer Centre · AURoyal Prince Alfred Hospital · AUUniversity of Oxford · GBCamden and Campbelltown Hospitals · AUGarvan Institute of Medical Research · AUJohn Radcliffe Hospital · GB

Funding

Cancer Research UK 11359
6 · The paper itself

Abstract

introductionBasal-like breast cancers behave more aggressively despite the presence of a dense lymphoid infiltrate. We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg.

methodsImmunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers. The hypoxia-associated marker carbonic anhydrase IX (CA9) and double FOXP3/CXCR4 staining were performed on sections from a subset of these cancers including 10 basal-like and 11 luminal cancers matched for tumour grade.

resultsHigh Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses. CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042). In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040). There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050). Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049).

conclusionsOur data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.

Indexed as

Cell HypoxiaAdultAgedAged, 80 and overAntigens, NeoplasmBiomarkers, TumorBreast NeoplasmsCarbonic Anhydrase IXCarbonic AnhydrasesChemokine CXCL12FemaleForkhead Transcription FactorsGene Expression Regulation, NeoplasticHumansMiddle AgedNeoplasm InvasivenessAntigens, NeoplasmBiomarkers, TumorCA9 protein, humanCarbonic Anhydrase IXCarbonic AnhydrasesChemokine CXCL12CXCL12 protein, humanCXCR4 protein, humanForkhead Transcription FactorsFOXP3 protein, humanReceptors, CXCR4

Identifiers

PMID21521526
PMCPMC3219210
OpenAlexW2167054695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.